T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V?3, V?14, and V?17 Peptides - Concepedia

Concepedia

Publication | Closed Access

T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V?3, V?14, and V?17 Peptides

73

Citations

53

References

1998

Year

Larry W. Moreland, Elizabeth E. Morgan, T. C. Adamson, Zdenka Fronek, Leonard H. Calabrese, Joseph M. Cash, Joseph A. Markenson, Alan K. Matsumoto, Joan M. Bathon, Eric L. Matteson,

Arthritis & Rheumatism

Abstract

IR501 therapeutic vaccine therapy was safe and well tolerated, immunogenic, and demonstrated clinical improvement in RA patients. Additional clinical trials are planned to confirm and extend these observations.

References

	Year	Citations

Page 1